Lonza Group AG (LONN)

Switzerland
Currency in CHF
Disclaimer
432.10
+5.80
(+1.36%)
Closed
Day's Range
426.20
436.80
52 wk Range
424.20
599.40
Volume
218,525
Bid/Ask
432.10 / 432.20
Prev. Close
426.3
Open
428
Day's Range
426.2-436.8
52 wk Range
424.2-599.4
Volume
218,525
Average Vol. (3m)
185,271
1-Year Change
-4.03%
Shares Outstanding
74,281,626
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
616.38
Upside +42.65%

People Also Watch

232.60
SIKA
-1.73%
154.67
PODD
-0.66%
114.25
CFR
-2.39%
94.68
SRENH
+0.57%
2,938.00
GIVN
-0.98%
How do you feel today about LONN?
Vote to see community's results!
or

Lonza Group AG Company Profile

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.

Income Statement